ezlopitant has been researched along with dexfenfluramine in 1 studies
| Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (dexfenfluramine) | Trials (dexfenfluramine) | Recent Studies (post-2010) (dexfenfluramine) |
|---|---|---|---|---|---|
| 22 | 2 | 1 | 226 | 17 | 20 |
| Protein | Taxonomy | ezlopitant (IC50) | dexfenfluramine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 3.403 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 3.403 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.516 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
1 other study(ies) available for ezlopitant and dexfenfluramine
| Article | Year |
|---|---|
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |